Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexis Bretteville

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Neurobiology of Aging|June 11, 2015
Dexmedetomidine increases tau phosphorylation under normothermic conditions in vivo and in vitroRobert A Whittington, László Virág, Maud Gratuze, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 28, 2008
Anesthesia-induced hyperphosphorylation detaches 3-repeat tau from microtubules without affecting their stability in vivoEmmanuel Planel, Pavan Krishnamurthy, Tomohiro Miyasaka, et al.
Molecular and Cellular Neurosciences|May 16, 2006
Pin1 allows for differential Tau dephosphorylation in neuronal cellsMalika Hamdane, Pierre Dourlen, Alexis Bretteville, et al.
Acta Neuropathologica Communications|September 24, 2015
Tau phosphorylation regulates the interaction between BIN1's SH3 domain and Tau's proline-rich domainYoann Sottejeau, Alexis Bretteville, François-Xavier Cantrelle, et al.
Journal of Medicinal Chemistry|November 16, 2020
Diazaspirononane Nonsaccharide Inhibitors of O-GlcNAcase (OGA) for the Treatment of Neurodegenerative DisordersCarlos M Martínez-Viturro, Andrés A Trabanco, Jordi Royes, et al.
ACS Medicinal Chemistry Letters|May 20, 2026
Discovery of 5‑Azaindole Inhibitors of O‑GlcNAcase for the Treatment of Alzheimer's Disease and Related TauopathiesJakob Bouton, Alexis Bretteville, Gary Tresadern, et al.
Stem Cell Reports|July 31, 2018
Genetically Engineered iPSC-Derived FTDP-17 MAPT Neurons Display Mutation-Specific Neurodegenerative and Neurodevelopmental PhenotypesAn Verheyen, Annick Diels, Joke Reumers, et al.
Neurobiology of Aging|August 29, 2012
Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarkerKunie Ando, Pierre Dourlen, Anne-Véronique Sambo, et al.
Glia|November 15, 2017
Systemic immune-checkpoint blockade with anti-PD1 antibodies does not alter cerebral amyloid-β burden in several amyloid transgenic mouse modelsMartine Latta-Mahieu, Bradford Elmer, Alexis Bretteville, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Neurobiology of Aging|June 11, 2015
Dexmedetomidine increases tau phosphorylation under normothermic conditions in vivo and in vitroRobert A Whittington, László Virág, Maud Gratuze, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 28, 2008
Anesthesia-induced hyperphosphorylation detaches 3-repeat tau from microtubules without affecting their stability in vivoEmmanuel Planel, Pavan Krishnamurthy, Tomohiro Miyasaka, et al.
Molecular and Cellular Neurosciences|May 16, 2006
Pin1 allows for differential Tau dephosphorylation in neuronal cellsMalika Hamdane, Pierre Dourlen, Alexis Bretteville, et al.
Acta Neuropathologica Communications|September 24, 2015
Tau phosphorylation regulates the interaction between BIN1's SH3 domain and Tau's proline-rich domainYoann Sottejeau, Alexis Bretteville, François-Xavier Cantrelle, et al.
Journal of Medicinal Chemistry|November 16, 2020
Diazaspirononane Nonsaccharide Inhibitors of O-GlcNAcase (OGA) for the Treatment of Neurodegenerative DisordersCarlos M Martínez-Viturro, Andrés A Trabanco, Jordi Royes, et al.
ACS Medicinal Chemistry Letters|May 20, 2026
Discovery of 5‑Azaindole Inhibitors of O‑GlcNAcase for the Treatment of Alzheimer's Disease and Related TauopathiesJakob Bouton, Alexis Bretteville, Gary Tresadern, et al.
Stem Cell Reports|July 31, 2018
Genetically Engineered iPSC-Derived FTDP-17 MAPT Neurons Display Mutation-Specific Neurodegenerative and Neurodevelopmental PhenotypesAn Verheyen, Annick Diels, Joke Reumers, et al.
Neurobiology of Aging|August 29, 2012
Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarkerKunie Ando, Pierre Dourlen, Anne-Véronique Sambo, et al.
Glia|November 15, 2017
Systemic immune-checkpoint blockade with anti-PD1 antibodies does not alter cerebral amyloid-β burden in several amyloid transgenic mouse modelsMartine Latta-Mahieu, Bradford Elmer, Alexis Bretteville, et al.
Pageof 3